Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.
For overlap across multiple ETFs use Portfolio Builder
18
Number of overlapping holdings
21.4%
% of WDNA's 90 holdings also in SYNB
54.5%
% of SYNB's 35 holdings also in WDNA
Overlap by Weight
Sector Drift (WDNA minus SYNB)
Overlapping Holdings
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
| Company | Weight in WDNA |
Weight in SYNB |
Overlap | |
|---|---|---|---|---|
 |
ELI LILLY & CO | 2.7% | 4.0% | 2.7% |
|
VERTEX PHARMACEUTICALS INC | 1.8% | 1.5% | 1.5% |
|
DUPONT DE NEMOURS INC | 1.5% | 3.5% | 1.5% |
|
TWIST BIOSCIENCE CORP. | 3.3% | 1.4% | 1.4% |
 |
ASTRAZENECA PLC-SPONS ADR | 1.4% | 4.2% | 1.4% |
Position Highlights (Non-Overlapping Exposures)
WDNA Overweight Relative to SYNB
|
NATERA INC | 3.7% |
 |
NOVOZYMES A/S-B SHARES | 2.9% |
|
BLUEPRINT MEDICINES CORP. | 2.6% |
|
VERICEL CORPORATION | 2.6% |
|
BRIDGEBIO PHARMA, INC. | 2.4% |
|
VERACYTE INC | 2.1% |
|
AGIOS PHARMACEUTICALS INC | 1.9% |
|
GILEAD SCIENCES INC | 1.9% |
|
TWIST BIOSCIENCE CORP. | 1.9% |
|
UNITED THERAPEUTICS CORP | 1.7% |
WDNA Underweight Relative to SYNB
|
ABBVIE INC | -5.5% |
|
THERMO FISHER SCIENTIFIC INC | -5.4% |
|
NOVOZYMES A/S-UNSPONS ADR | -4.6% |
|
DANAHER CORP | -4.2% |
|
ASCENDIS PHARMA A/S | -4.0% |
|
ALPHABET INC. CLASS A | -3.9% |
|
BIO-RAD LABORATORIES-CL A | -3.8% |
|
NVIDIA CORP | -3.5% |
|
CORTEVA INC | -3.5% |
|
ASTRAZENECA PLC-SPONS ADR | -2.9% |